| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/27/2011 | US20110021468 Treatment of cardiovascular disease with salicylates |
| 01/27/2011 | US20110021467 Indazolecarboxamide derivatives for the treatment and prevention of malaria |
| 01/27/2011 | US20110021466 Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling |
| 01/27/2011 | US20110021465 Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome |
| 01/27/2011 | US20110021464 Methods of treating viral infections |
| 01/27/2011 | US20110021462 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 01/27/2011 | US20110021461 Combinations to improve animal health and performance |
| 01/27/2011 | US20110021459 Dutpase inhibitors |
| 01/27/2011 | US20110021458 Pharmaceutical compositions containing an inclusion complex formed by disulfiram and a cyclodextrine, which can be used in the treatment of alcohol and cocaine dependence |
| 01/27/2011 | US20110021457 Pharmaceutical compositions comprising modified fucans and methods relating thereto |
| 01/27/2011 | US20110021456 Sweetening compositions and processes for preparing them |
| 01/27/2011 | US20110021455 Sterilised sucralfate gel |
| 01/27/2011 | US20110021454 Modified 4`-nucleosides as antiviral agents |
| 01/27/2011 | US20110021453 Methods and compositions for providing cardiac protection |
| 01/27/2011 | US20110021452 Lyophilized preparation of stabilized anthracycline compounds |
| 01/27/2011 | US20110021451 Lipid tumour profile |
| 01/27/2011 | US20110021450 Medicinal composition containing benzo[a]phenoxazine compound as the active ingredient for prevention or treatment of protozoal disease |
| 01/27/2011 | US20110021449 Macrolides and uses of macrolides |
| 01/27/2011 | US20110021448 Inhibitors for the Soluble Epoxide Hydrolase |
| 01/27/2011 | US20110021447 Acne treatment composition and methods for using |
| 01/27/2011 | US20110021446 Compositions and methods for feeding poultry |
| 01/27/2011 | US20110021443 OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES |
| 01/27/2011 | US20110021441 Conjugate comprising p21 protein for the treatment of cancer |
| 01/27/2011 | US20110021439 Use of transesterified olive oil in the cosmetic field |
| 01/27/2011 | US20110021437 Method for reducing pain with ziconotide and baclofen |
| 01/27/2011 | US20110021436 Method for reducing pain with ziconotide and morphine |
| 01/27/2011 | US20110021425 Tricyclic inhibitors of jak |
| 01/27/2011 | US20110021417 Compositions comprising oligosaccharides |
| 01/27/2011 | US20110021416 Compositions, methods and uses for treating bacterial infections |
| 01/27/2011 | US20110021413 Methods of suppressing microglial activation |
| 01/27/2011 | US20110021412 Human Receptor Proteins; Related Reagents and Methods |
| 01/27/2011 | US20110021377 Use of a trpc channel for the treatment of a cardiovascular disease |
| 01/27/2011 | US20110021365 Nucleic Acid Binding Compounds Containing Pyrazolo[3,4-D]Pyrimidine Analogues of Purin-2,6-Diamine and Their Uses |
| 01/27/2011 | US20110020928 Immunovectors which can be used for the intracellular and intranuclear transport |
| 01/27/2011 | US20110020478 Method for treating neural injuries |
| 01/27/2011 | US20110020477 Oral preparation, injection preparation, external skin preparation and cosmetic method for preventing or improving wrinkles |
| 01/27/2011 | US20110020471 Erythrocyte atp-release modulators |
| 01/27/2011 | US20110020470 Methods and compositions for treating cancer |
| 01/27/2011 | US20110020469 Aminopyrimidines useful as kinase inhibitors |
| 01/27/2011 | US20110020467 Inhibition of Biogenic Sulfide Production Via Biocide and Metabolic Inhibitor Combination |
| 01/27/2011 | US20110020463 Therapeutic agent for fibromyalgia syndrome and therapeutic agent for pain caused by muscle spasm |
| 01/27/2011 | US20110020462 New use of histone deacetylase inhibitors in changing mrjp3 protein in royal jelly |
| 01/27/2011 | US20110020460 Gpr 119 modulators |
| 01/27/2011 | US20110020457 Polymer-surfactant nanoparticles for sustained release of compounds |
| 01/27/2011 | US20110020455 Solid dispersion and pharmaceutical composition of the same, and production processes thereof |
| 01/27/2011 | US20110020454 Novel dosage and formulation |
| 01/27/2011 | US20110020453 Topical Formulations Comprising Ion Channel Modulators |
| 01/27/2011 | US20110020451 Tamper-resistant dosage form for oxidation-sensitive opioids |
| 01/27/2011 | US20110020450 Titratable dosage transdermal delivery system |
| 01/27/2011 | US20110020448 Pharmaceutical composition for the treatment and prevention of glaucoma |
| 01/27/2011 | US20110020447 Novel dosage form |
| 01/27/2011 | US20110020446 Methods and formulations for making pharmaceutical compositions containing bupropion |
| 01/27/2011 | US20110020445 Extended release pharmaceutical compositions of levetiracetam |
| 01/27/2011 | US20110020444 Abuse-resistant opioid dosage form |
| 01/27/2011 | US20110020443 Slow release magnesium composition and uses thereof |
| 01/27/2011 | US20110020442 Taste Masked Oral Composition of Telithromycin |
| 01/27/2011 | US20110020441 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 01/27/2011 | US20110020440 Stable solutions of sparingly soluble actives |
| 01/27/2011 | US20110020439 Delayed release compositions of duloxetine |
| 01/27/2011 | US20110020438 Crystallization Inhibitor and Its Use in Gelatin Capsules |
| 01/27/2011 | US20110020437 Oligopeptidic compounds and uses thereof |
| 01/27/2011 | US20110020436 Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes |
| 01/27/2011 | US20110020434 Nanoparticle arsenic-platinum compositions |
| 01/27/2011 | US20110020433 Compositions for delivery of cargo such as drugs proteins and/or genetic materials |
| 01/27/2011 | US20110020431 Antitumor effect of mutant bik |
| 01/27/2011 | US20110020430 Novel mRNA splice variant of the doublecortin-like kinase gene and its use in cancer diagnosis and therapy |
| 01/27/2011 | US20110020429 Use of particles comprising an alcohol |
| 01/27/2011 | US20110020428 Gel-stabilized liposome compositions, methods for their preparation and uses thereof |
| 01/27/2011 | US20110020427 Method Of Treating Malignant Solid Tumors Using Transcatheter Arterial Chemoembolization (TACE) |
| 01/27/2011 | US20110020426 Process for the continuous manufacture of a polyisobutylene based transdermal patch |
| 01/27/2011 | US20110020424 Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds |
| 01/27/2011 | US20110020423 Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| 01/27/2011 | US20110020422 Hydroxyapatite-Targeting Poly(ethylene glycol) and Related Polymers |
| 01/27/2011 | US20110020421 Biodegradable polyphosphazenes containing pyrrolidone side groups |
| 01/27/2011 | US20110020418 Particulate Tissue Graft with Components of Differing Density and Methods of Making and Using the Same |
| 01/27/2011 | US20110020412 Novel dosage and formulation |
| 01/27/2011 | US20110020410 Stable solid preparations |
| 01/27/2011 | US20110020408 multilayered modified release formulation comprising amoxicillin and clavulanate |
| 01/27/2011 | US20110020407 Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy |
| 01/27/2011 | US20110020399 Vaccines and Immunomodulatory Therapies for Tularemia |
| 01/27/2011 | US20110020377 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020376 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020368 Treating cancer by down-regulating frizzled-4 and/or frizzled-1 |
| 01/27/2011 | US20110020367 Methods of Evaluating Transplant Rejection |
| 01/27/2011 | US20110020366 Use of benzophenone derivative or salt thereof and tnf alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 01/27/2011 | US20110020364 Methods and compositions involving pbef inhibitors for lung inflammation conditions and diseases |
| 01/27/2011 | US20110020362 Adrenergic stimulation mediates hypersensitivity by inducing nerve growth factor expression |
| 01/27/2011 | US20110020352 Endogenous retroviruses up-regulated in prostate cancer |
| 01/27/2011 | US20110020338 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes |
| 01/27/2011 | US20110020337 Methods for treating conditions associated with masp-2 dependent complement activation |
| 01/27/2011 | US20110020336 Combination Of A Beta-Glucan And An EGF Receptor Antagonist For The Treatment Of Cancer And Infection |
| 01/27/2011 | US20110020335 Treatment of Cancers Expressing p95 ErbB2 |
| 01/27/2011 | US20110020325 Methods for reducing granulomatous inflammation |
| 01/27/2011 | US20110020324 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 01/27/2011 | US20110020321 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/27/2011 | US20110020317 Breast tumour grading |
| 01/27/2011 | US20110020316 Composition and method to alleviate joint pain |
| 01/27/2011 | US20110020315 Treatment of inflammatory illnesses with ace2 |
| 01/27/2011 | US20110020313 Method of using and establishing an absorption rate level and a neuron firing level |
| 01/27/2011 | US20110020312 Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |